527 related articles for article (PubMed ID: 23810671)
1. Anti-inflammatory and anti-apoptotic effects of (RS)-glucoraphanin bioactivated with myrosinase in murine sub-acute and acute MPTP-induced Parkinson's disease.
Galuppo M; Iori R; De Nicola GR; Bramanti P; Mazzon E
Bioorg Med Chem; 2013 Sep; 21(17):5532-47. PubMed ID: 23810671
[TBL] [Abstract][Full Text] [Related]
2. (RS)-glucoraphanin purified from Tuscan black kale and bioactivated with myrosinase enzyme protects against cerebral ischemia/reperfusion injury in rats.
Giacoppo S; Galuppo M; Iori R; De Nicola GR; Bramanti P; Mazzon E
Fitoterapia; 2014 Dec; 99():166-77. PubMed ID: 25281776
[TBL] [Abstract][Full Text] [Related]
3. RS-Glucoraphanin bioactivated with myrosinase treatment counteracts proinflammatory cascade and apoptosis associated to spinal cord injury in an experimental mouse model.
Galuppo M; Giacoppo S; De Nicola GR; Iori R; Mazzon E; Bramanti P
J Neurol Sci; 2013 Nov; 334(1-2):88-96. PubMed ID: 23992921
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of (RS)-glucoraphanin on the tight junction dysfunction in a mouse model of restraint stress.
Foti Cuzzola V; Galuppo M; Iori R; De Nicola GR; Cassata G; Giacoppo S; Bramanti P; Mazzon E
Life Sci; 2013 Aug; 93(7):288-305. PubMed ID: 23871805
[TBL] [Abstract][Full Text] [Related]
5. Protective role of (RS )-glucoraphanin bioactivated with myrosinase in an experimental model of multiple sclerosis.
Giacoppo S; Galuppo M; Iori R; De Nicola GR; Cassata G; Bramanti P; Mazzon E
CNS Neurosci Ther; 2013 Aug; 19(8):577-84. PubMed ID: 23638842
[TBL] [Abstract][Full Text] [Related]
6. The protective effects of bioactive (RS)-glucoraphanin on the permeability of the mice blood-brain barrier following experimental autoimmune encephalomyelitis.
Giacoppo S; Galuppo M; Iori R; De Nicola GR; Bramanti P; Mazzon E
Eur Rev Med Pharmacol Sci; 2014; 18(2):194-204. PubMed ID: 24488908
[TBL] [Abstract][Full Text] [Related]
7. Ropinirole protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism.
Park G; Park YJ; Yang HO; Oh MS
Pharmacol Biochem Behav; 2013 Mar; 104():163-8. PubMed ID: 23369986
[TBL] [Abstract][Full Text] [Related]
8. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats.
Xu CL; Qu R; Zhang J; Li LF; Ma SP
Fitoterapia; 2013 Oct; 90():112-8. PubMed ID: 23876367
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses.
Lofrumento DD; Nicolardi G; Cianciulli A; De Nuccio F; La Pesa V; Carofiglio V; Dragone T; Calvello R; Panaro MA
Innate Immun; 2014 Apr; 20(3):249-60. PubMed ID: 23764428
[TBL] [Abstract][Full Text] [Related]
12. Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions.
Lee JM; Hwang DS; Kim HG; Lee CH; Oh MS
J Ethnopharmacol; 2012 Feb; 139(3):883-8. PubMed ID: 22178176
[TBL] [Abstract][Full Text] [Related]
13. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
[TBL] [Abstract][Full Text] [Related]
14. Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models.
Kim HG; Ju MS; Shim JS; Kim MC; Lee SH; Huh Y; Kim SY; Oh MS
Br J Nutr; 2010 Jul; 104(1):8-16. PubMed ID: 20187987
[TBL] [Abstract][Full Text] [Related]
15. Preventive role of PD-1 on MPTP-induced dopamine depletion in mice.
Jung HW; Son HY; Jin GZ; Park YK
Cell Biochem Funct; 2010 Apr; 28(3):217-23. PubMed ID: 20186864
[TBL] [Abstract][Full Text] [Related]
16. Neuronal or inducible nitric oxide synthase (NOS) expression level is not involved in the different susceptibility to nigro-striatal dopaminergic neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) between C57BL/6 and BALB/c mice.
Ito T; Uchida K; Nakayama H
Exp Toxicol Pathol; 2013 Jan; 65(1-2):121-5. PubMed ID: 21788124
[TBL] [Abstract][Full Text] [Related]
17. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
Kubo K; Inada T; Shingu K
Brain Res; 2011 Apr; 1387():125-33. PubMed ID: 21376018
[TBL] [Abstract][Full Text] [Related]
18. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
[TBL] [Abstract][Full Text] [Related]
19. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of riluzole in early phase Parkinson's disease on clinically relevant parameters in the marmoset MPTP model.
Verhave PS; Jongsma MJ; Van Den Berg RM; Vanwersch RA; Smit AB; Philippens IH
Neuropharmacology; 2012 Mar; 62(4):1700-7. PubMed ID: 22178201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]